Loupakis, Fotios
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.113
AS - Asia 134
EU - Europa 103
Totale 2.350
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.111
CN - Cina 125
IT - Italia 28
FI - Finlandia 20
DE - Germania 17
GB - Regno Unito 15
SE - Svezia 13
IN - India 6
UA - Ucraina 5
CA - Canada 2
FR - Francia 2
IE - Irlanda 2
IR - Iran 2
KH - Cambogia 1
MK - Macedonia 1
Totale 2.350
Salva come PNG Salva come JPEG
Città #
Fairfield 456
Chandler 225
Woodbridge 188
Ashburn 183
Cambridge 179
Seattle 178
Houston 136
Wilmington 117
Ann Arbor 99
San Diego 49
Beijing 31
Medford 27
Princeton 27
Des Moines 21
Helsinki 20
Padova 12
Boardman 10
Saint Louis 10
Jinan 9
Nanchang 9
Los Angeles 8
Nanjing 8
Changsha 7
Roxbury 7
Hefei 6
London 6
New York 6
Guangzhou 5
Kunming 5
Kilburn 3
Ningbo 3
Taizhou 3
Tappahannock 3
Chengdu 2
Dublin 2
Hangzhou 2
Hebei 2
Kharkiv 2
Lanzhou 2
Longobucco 2
New Bedfont 2
Seregno 2
Shanghai 2
Shenyang 2
Soemmerda 2
Tehran 2
Terni 2
Trento 2
Cesena 1
Chicago 1
Chongqing 1
Dolo 1
Dongguan 1
Elk Grove Village 1
Erding 1
Haikou 1
Hanover 1
Norwalk 1
Ogden 1
Phnom Penh 1
Phoenix 1
Pisa 1
Prescot 1
Pune 1
Quzhou 1
Redwood City 1
San Francisco 1
Stockholm 1
Taiyuan 1
Tianjin 1
Toronto 1
Trieste 1
Wenzhou 1
Zhengzhou 1
Totale 2.112
Salva come PNG Salva come JPEG
Nome #
Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization 164
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 146
BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling 130
LONG-NONCODING RNAs in gastroesophageal cancers 127
An overview on clinical, pathological and molecular features of lung metastases from colorectal cancer 125
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer 123
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 115
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 111
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study 110
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 104
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis 97
PD-L1 expression in gastroesophageal dysplastic lesions 90
Precision medicine in cholangiocarcinoma 84
Tumor mutation burden: From comprehensive mutational screening to the clinic 77
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status 72
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer? 71
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (Cancer Cell International (2018) 18 (131) DOI: 10.1186/s12935-018-0634-8) 70
PTEN in colorectal cancer: Shedding light on its role as predictor and target 63
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population 63
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer 63
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 60
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis 57
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives 56
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial 54
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis 53
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab 52
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes 45
Totale 2.382
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.530
article - articoli 8.530
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201981 0 0 0 0 0 0 0 0 0 0 34 47
2019/2020795 38 25 37 205 56 46 91 76 86 51 42 42
2020/2021490 33 107 21 25 14 46 21 64 55 54 29 21
2021/2022460 21 55 51 34 25 17 42 44 14 10 47 100
2022/2023374 71 54 5 72 37 32 1 27 42 9 19 5
2023/2024156 11 40 22 15 12 20 19 2 6 9 0 0
Totale 2.382